StockWatch
·

PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD.

BSE: 500459

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
1.2K
+29.0%+0.2%
Expenditure
900.07
+23.1%+2.5%
Net Profit
195.84
+55.1%-6.7%
OPM %
22.72%
+3.64pp-2.04pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00356.81713.611.1K1.4KQ1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

P&G Hygiene Q2 FY27: standalone PAT down 6.7% YoY on margin compression, revenue flat

fmcg · hygiene products · margin compression

ResultsQ2 FY2712 Nov 20263 minFMCG

Can P&G Hygiene stabilise sales? Q2 print arrives after 5% Q1 decline

FMCG · revenue growth · margin pressure

Result previewQ2 FY2708 Nov 20263 minFMCG

P&G Hygiene Q1 profit slides 34% YoY to ₹126 Cr as margins compress on input, ad costs

fmcg · consumer staples · margin compression

ResultsQ1 FY2729 Jul 20263 minFMCG
Latest
Quarterly Result12 Nov, 1:38 pm

P&G Hygiene Q2 FY27: standalone PAT down 6.7% YoY on margin compression, revenue flat

Procter & Gamble Hygiene and Health Care's Q2 FY27 standalone revenue was ₹1,145.08 Cr, down 0.44% YoY from ₹1,150.17 Cr and up 28.5% QoQ from ₹891.46 Cr. The sequential jump is a festive-quarter seasonal pattern typical of this FMCG franchise and should not be read as a trend reversal — YoY is flat, not growing. Standalone PAT was ₹195.84 Cr, down 6.7% YoY from ₹209.86 Cr, even as it rose 55.1% QoQ off Q1's depressed ₹126.27 Cr base; that QoQ strength is a low-base/seasonal artifact, not a turnaround. EPS was ₹60.33 versus ₹64.65 a year ago. Revenue came in well ahead of Street: MOFSL had modelled Q2 revenue near ₹1,000 Cr, so the print beat that estimate by roughly 14-15%; no third-party PAT estimate could be located for cross-check. Operating margin (PBT + finance cost + depreciation − other income, over revenue) was 22.72%, down from 24.76% a year ago (-204 bps), while net margin (PAT/total income) was 16.85% versus 18.09% (-124 bps). The compression traces to raw-material-and-traded-goods costs, which rose to 41.1% of revenue from 38.7% a year ago — a continuation of the commodity-cost pressure management flagged on the Q1 FY27 call, when it attributed a 34.3% YoY PAT decline and a 933-bps EBITDA margin collapse to geopolitically-driven crude and resin cost inflation. This quarter's YoY margin and profit erosion is materially smaller than Q1's, suggesting the worst of the commodity pass-through lag may be easing. Advertising & sales promotion spend was ₹166.62 Cr (14.55% of revenue), down slightly from ₹175.97 Cr (15.30% of revenue) a year ago, even though it nearly doubled sequentially from Q1's ₹83.32 Cr — again a seasonal festive-quarter step-up rather than a new elevated spending stance. The company has not issued formal quantitative guidance (no prior concall read or guidance figure on record), so this result cannot be graded against a specific numeric target. Qualitatively, management said on the Q1 call that commodity-cost challenges would persist through FY27 while expressing confidence in its growth strategy; this quarter's continued but narrower margin compression is consistent with, not contradictory to, that framing. The filing confirms (Note 8) the company has no subsidiary, associate or joint venture, so standalone is the complete and only reported basis — there is no separate consolidated number to reconcile against, and no exceptional items or one-off charges appear in the statement.

12 Nov 2026, 01:38 pm

Corporate Events

Board MeetingPGHH
2026
12Nov

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingPGHH
2026
8Sep

Board Meeting

The shareholders of the Company approved the appointment of …

BSE Filing ↗
Board MeetingPGHH
2026
2Sep

Board Meeting

The Company has informed the Exchange regarding revised Reco…

BSE Filing ↗
DividendPGHH
2026
26Aug

₹60 / share

BSE Filing ↗
Board MeetingPGHH
2026
29Jul

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingPGHH
2026
28May

Board Meeting

To consider and approve Audited Financial Statements for the…

BSE Filing ↗
Board MeetingPGHH
2026
30Jan

Board Meeting

Consider and approve The ..., declare interim dividend for t…

BSE Filing ↗
Board MeetingPGHH
2025
11Feb

Board Meeting

declaration of interim dividend for the financial year 2024-…

BSE Filing ↗
DividendPGHH
2024
18Nov

₹95 / share

BSE Filing ↗
Board MeetingPGHH
2024
30Oct

Board Meeting

Consideration and Approval Of The Unaudited Financial Result…

BSE Filing ↗
Board MeetingPGHH
2024
29Aug

Board Meeting

Consider and approve audited financial results and statement…

BSE Filing ↗
DividendPGHH
2024
28Aug

₹95 / share

BSE Filing ↗
DividendPGHH
2024
9Feb

₹160 / share

BSE Filing ↗
Board MeetingPGHH
2024
31Jan

Board Meeting

Consider and approve Unaudited Financial Results for the Qua…

BSE Filing ↗
DividendPGHH
2023
17Nov

₹105 / share

BSE Filing ↗
Board MeetingPGHH
2023
30Oct

Board Meeting

Consider and approve the Unaudited Financial Results for the…

BSE Filing ↗